Resultados da pesquisa - safety after last phase role

Pesquisas alternativas:
after last » after blast (Expandir a Pesquisa), after laser (Expandir a Pesquisa), after lasik (Expandir a Pesquisa)
last phase » blast phase (Expandir a Pesquisa), yeast phase (Expandir a Pesquisa), gait phase (Expandir a Pesquisa)
phase role » phase rule (Expandir a Pesquisa), phase route (Expandir a Pesquisa), phase whole (Expandir a Pesquisa)

1

Phase 1A safety assessment of intravenous amitriptyline

Phase 1A safety assessment of intravenous amitriptyline

Por Fridrich, Peter, Colvin, Hans Peter, Zizza, Anthony, Wasan, Ajay D., Lukanich, Jean, Lirk, Philipp, Saria, Alois, Zernig, Gerald, Hamp, Thomas, Gerner, Peter
Publicado em 2007

“... effects of preoperative intravenous amitriptyline in a typical phase 1A trial. After obtaining written...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide

A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide

Por Uday Kulkarni, Saravanan Ganesan, Ansu Abu Alex, Hamenth Palani, Sachin David, Nithya Balasundaram, Arvind Venkatraman, Mani Thenmozhi, Lakshmanan Jeyaseelan, Anu Korula, Anup Devasia, Aby Abraham, Nancy Beryl Janet, Poonkuzhali Balasubramanian, Biju George, Vikram Mathews
Publicado em 2020-04-01

“...Abstract The standard‐of‐care for patients with acute promyelocytic leukemia (APL) relapsing after...”
Obter o texto integral

Artigo

3

Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer

Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer

Por Ricciardi, Serena, Tomao, Silverio, de Marinis, Filippo
Publicado no Lung Cancer (Auckl) (2010)

“... receptor (EGFR) has played a central role in advancing non-small-cell lung cancer (NSCLC) research...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

4

$Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer$

Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer

Por Fogelman, David, Cubillo, Antonio, García‐Alfonso, Pilar, Mirón, María Luisa Limón, Nemunaitis, John, Flora, Daniel, Borg, Christophe, Mineur, Laurent, Vieitez, Jose M., Cohn, Allen, Saylors, Gene, Assad, Albert, Switzky, Julie, Zhou, Li, Bendell, Johanna
Publicado no Cancer Med (2018)

“..., and Israel. After an open‐label, safety run‐in phase (part 1; ruxolitinib 20 mg twice daily [BID] plus...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

5

Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02

Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02

Por Roestenberg, Meta, Remarque, Ed, de Jonge, Erik, Hermsen, Rob, Blythman, Hildur, Leroy, Odile, Imoukhuede, Egeruan, Jepsen, Soren, Ofori-Anyinam, Opokua, Faber, Bart, Kocken, Clemens H. M., Arnold, Miranda, Walraven, Vanessa, Teelen, Karina, Roeffen, Will, de Mast, Quirijn, Ballou, W. Ripley, Cohen, Joe, Dubois, Marie Claude, Ascarateil, Stéphane, van der Ven, Andre, Thomas, Alan, Sauerwein, Robert
Publicado em 2008

“... expressed by merozoites and sporozoites. It plays a key role in red blood cell and hepatocyte invasion...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

6

Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?

Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?

Por Harrison, Michael R.
Publicado em 2011

“... in its class. The efficacy and safety of pazopanib in Phase I, II, and III trials will be examined...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

7

Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia

Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia

Por Brasso, Claudio, Bellino, Silvio, Bozzatello, Paola, Montemagni, Cristiana, Rocca, Paola
Publicado no Neuropsychiatr Dis Treat (2017)

“... to these last 9 studies, when compared with placebo, PP3M showed a longer time to relapse and good safety...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer – PARC: study protocol [ISRCTN56652283]

Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination...

Por Krempien, R, Muenter, MW, Huber, PE, Nill, S, Friess, H, Timke, C, Didinger, B, Buechler, P, Heeger, S, Herfarth, KK, Abdollahi, A, Buchler, MW, Debus, J
Publicado em 2005

“... will be enrolled. An interim analysis for patient safety reasons will be done one year after start of recruitment...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

9

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial

Por Coleman, Robert L, Brady, Mark F, Herzog, Thomas J, Sabbatini, Paul, Armstrong, Deborah K, Walker, Joan L, Kim, Byoung-Gie, Fujiwara, Keiichi, Tewari, Krishnansu S, O'Malley, David M, Davidson, Susan A, Rubin, Stephen C, DiSilvestro, Paul, Basen-Engquist, Karen, Huang, Helen, Chan, John K, Spirtos, Nick M, Ashfaq, Raheela, Mannel, Robert S
Publicado no Lancet Oncol (2017)

“... cancer recurring 6 months after completion of initial therapy. In this study, we aimed to explore...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

10

Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759]

Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external...

Por Knaebel, HP, Märten, A, Schmidt, J, Hoffmann, K, Seiler, C, Lindel, K, Schmitz-Winnenthal, H, Fritz, S, Herrmann, T, Goldschmidt, H, Mansmann, U, Debus, J, Diehl, V, Büchler, MW
Publicado em 2005

“.... An interim analysis for patient safety reasons will be done one year after start of recruitment. Evaluation...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

11

Dispensing patterns of selective serotonin reuptake inhibitors before, during and after pregnancy: a 16-year population-based cohort study from the Netherlands

Dispensing patterns of selective serotonin reuptake inhibitors before, during and after pregnancy: a 16-year population-based cohort study from the Netherlands

Por Molenaar, Nina Maren, Lambregtse-van den Berg, Mijke Pietertje, Bonsel, Gouke Jacobus
Publicado no Arch Womens Ment Health (2019)

“... and the role of a recently issued guideline in this regard. We identified a 16-year cohort of 153,952 Dutch...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

12

Regorafenib: an evidence-based review of its potential in patients with advanced liver cancer

Regorafenib: an evidence-based review of its potential in patients with advanced liver cancer

Por Ravi, Sujan, Singal, Ashwani K
Publicado em 2014

“... potential in preclinical models. After its safety and pharmacological properties was studied in Phase I...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

13

The promise of CAR T-cell therapy in aggressive B-cell lymphoma

The promise of CAR T-cell therapy in aggressive B-cell lymphoma

Por Nair, Ranjit, Neelapu, Sattva S.
Publicado no Best Pract Res Clin Haematol (2018)

“... of chimeric antigen receptor (CAR) T-cell therapy. Within the last one year, two anti-CD19 CAR T-cell therapy...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

14

Legal Background of Aviation Medicine in Europe and its future development

Legal Background of Aviation Medicine in Europe and its future development

Por Siedenburg, J
Publicado em 2008

“... that aviation safety had to be regulated by the EU commission. After adoption of EU regulation 1592/2002 in 2002...”
Obter o texto integral
Obter o texto integral

Artigo

15

Plitidepsin: design, development, and potential place in therapy

Plitidepsin: design, development, and potential place in therapy

Por Alonso-Álvarez, Sara, Pardal, Emilia, Sánchez-Nieto, Diego, Navarro, Miguel, Caballero, Maria Dolores, Mateos, Maria Victoria, Martín, Alejandro
Publicado no Drug Des Devel Ther (2017)

“... clinical trials to be conducted over the last 17 years, alone or in combination with other anticancer...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration

Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bispho...

Por Wardley, A, Davidson, N, Barrett-Lee, P, Hong, A, Mansi, J, Dodwell, D, Murphy, R, Mason, T, Cameron, D
Publicado em 2005

“... therapy. After a lead-in phase of three infusions of 4 mg zoledronic acid in the hospital setting, 101...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

17

Design and rationale of the AngioSeal versus the Radial approach In acute coronary SyndromE (ARISE) trial: a randomized comparison of a vascular closure device versus the radial approach to prevent vascular access site complications in non-ST-segment elevation acute coronary syndrome patients

Design and rationale of the AngioSeal versus the Radial approach In acute coronary SyndromE (ARISE) trial: a randomized comparison of a vascular closure device versus the radial ap...

Por de Andrade, Pedro Beraldo, e Mattos, Luiz Alberto Piva, Tebet, Marden André, Rinaldi, Fábio Salerno, Esteves, Vinícius Cardozo, Nogueira, Ederlon Ferreira, França, João Ítalo Dias, de Andrade, Mônica Vieira Athanazio, Barbosa, Robson Alves, Labrunie, André, Abizaid, Alexandre Antônio Cunha, Sousa, Amanda Guerra de Moraes Rego
Publicado em 2013

“... October 2013 91 patients were included. The inclusion phase is expected to last until the second half...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

18

The world's first malaria vaccine – promising clinical results

The world's first malaria vaccine – promising clinical results

Por Iga Dudek, Jakub Czarnota, Danuta Hajduga, Michał Dobrzyński, Magdalena Marzęda
Publicado em 2019-09-01

“... germ that contributes to the highest number of deaths from malaria. After passing the three phases...”
Obter o texto integral

Artigo

19

Esophageal, gastric cancer and immunotherapy: small steps in the right direction?

Esophageal, gastric cancer and immunotherapy: small steps in the right direction?

Por Zayac, Adam, Almhanna, Khaldoun
Publicado no Transl Gastroenterol Hepatol (2020)

“...The treatment of advanced, solid-tumor oncology has been reshaped over the last eight years...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

20

Drug Testing in Oral Fluid

Drug Testing in Oral Fluid

Por Drummer, Olaf H
Publicado em 2006

“...Over the last decade there have been considerable developments in the use of oral fluid (saliva...”
Obter o texto integral
Obter o texto integral

Artigo